Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

Background. Concomitant use of rifamycins to treat or prevent tuberculosis can result in subtherapeutic concentrations of antiretroviral drugs. We studied the interaction of efavirenz with daily rifapentine and isoniazid in human immunodeficiency virus (HIV)–infected individuals receiving a 4-week r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Infect Dis
Hauptverfasser: Podany, Anthony T., Bao, Yajing, Swindells, Susan, Chaisson, Richard E., Andersen, Janet W., Mwelase, Thando, Supparatpinyo, Khuanchai, Mohapi, Lerato, Gupta, Amita, Benson, Constance A., Kim, Peter, Fletcher, Courtney V.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2015
Schlagworte:
HIV/AIDS
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4583578/
https://ncbi.nlm.nih.gov/pubmed/26082504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ464
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge